BFA
FURX

BlackRock Fund Advisors’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

BlackRock Fund Advisors’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-221,068
Closed -$23.5M – 3948
2014
Q2 		$23.5M Sell
221,068
-34,431
-13% -$3.38M 0.01% 1924
2014
Q1 		$22.2M Buy
255,499
+73,540
+40% +$5.68M 0.01% 1941
2013
Q4 		$7.64M Sell
181,959
-119,167
-40% -$4.9M ﹤0.01% 2540
2013
Q3 		$13.2M Buy
301,126
+40,749
+16% +$1.69M ﹤0.01% 2192
2013
Q2 		$8.87M Buy
+260,377
New +$9.14M ﹤0.01% 2319

BlackRock Fund Advisors's FURX Position: Q3 2014 in Review

BlackRock Fund Advisors sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 221,068 shares — an estimated $23.5M sold.

BlackRock Fund Advisors first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $23.5M in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • BlackRock Fund Advisors reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • BlackRock Fund Advisors sold 221,068 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $23.5M.
  • BlackRock Fund Advisors first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • BlackRock Fund Advisors's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $23.5M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on BlackRock Fund Advisors's 13F filing for Q3 2014, filed 29 Oct 2014.